Cargando…
New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
(1) Background: In their 60-year history, dimethyl fumarate and other salts of fumaric acid have been used for the treatment of psoriasis and other immune-mediated diseases for their immune-modulating properties. Over the years, new mechanisms of action have been discovered for this evergreen drug t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788528/ https://www.ncbi.nlm.nih.gov/pubmed/36559226 http://dx.doi.org/10.3390/pharmaceutics14122732 |
_version_ | 1784858775825416192 |
---|---|
author | Matteo, Paolinelli Federico, Diotallevi Emanuela, Martina Giulia, Radi Tommaso, Bianchelli Alfredo, Giacchetti Anna, Campanati Annamaria, Offidani |
author_facet | Matteo, Paolinelli Federico, Diotallevi Emanuela, Martina Giulia, Radi Tommaso, Bianchelli Alfredo, Giacchetti Anna, Campanati Annamaria, Offidani |
author_sort | Matteo, Paolinelli |
collection | PubMed |
description | (1) Background: In their 60-year history, dimethyl fumarate and other salts of fumaric acid have been used for the treatment of psoriasis and other immune-mediated diseases for their immune-modulating properties. Over the years, new mechanisms of action have been discovered for this evergreen drug that remains a first-line treatment for several different inflammatory diseases. Due to its pleiotropic effects, this molecule is still of great interest in varied conditions, not exclusively inflammatory diseases. (2) Methods: The PubMed database was searched using combinations of the following keywords: dimethyl fumarate, pharmacokinetics, pharmacodynamics, adverse effects, psoriasis, multiple sclerosis, and clinical indications. This article reviews and updates the pharmacokinetics, mechanisms of action, and clinical indications of dimethyl fumarate. (3) Conclusions: The pharmacology of dimethyl fumarate is complex, fascinating, and not fully known. Progressive insights into the molecule’s mechanisms of action will make it possible to maximize its clinical efficacy, reduce concerns about adverse effects, and find other possible areas of application. |
format | Online Article Text |
id | pubmed-9788528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97885282022-12-24 New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate Matteo, Paolinelli Federico, Diotallevi Emanuela, Martina Giulia, Radi Tommaso, Bianchelli Alfredo, Giacchetti Anna, Campanati Annamaria, Offidani Pharmaceutics Review (1) Background: In their 60-year history, dimethyl fumarate and other salts of fumaric acid have been used for the treatment of psoriasis and other immune-mediated diseases for their immune-modulating properties. Over the years, new mechanisms of action have been discovered for this evergreen drug that remains a first-line treatment for several different inflammatory diseases. Due to its pleiotropic effects, this molecule is still of great interest in varied conditions, not exclusively inflammatory diseases. (2) Methods: The PubMed database was searched using combinations of the following keywords: dimethyl fumarate, pharmacokinetics, pharmacodynamics, adverse effects, psoriasis, multiple sclerosis, and clinical indications. This article reviews and updates the pharmacokinetics, mechanisms of action, and clinical indications of dimethyl fumarate. (3) Conclusions: The pharmacology of dimethyl fumarate is complex, fascinating, and not fully known. Progressive insights into the molecule’s mechanisms of action will make it possible to maximize its clinical efficacy, reduce concerns about adverse effects, and find other possible areas of application. MDPI 2022-12-06 /pmc/articles/PMC9788528/ /pubmed/36559226 http://dx.doi.org/10.3390/pharmaceutics14122732 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Matteo, Paolinelli Federico, Diotallevi Emanuela, Martina Giulia, Radi Tommaso, Bianchelli Alfredo, Giacchetti Anna, Campanati Annamaria, Offidani New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate |
title | New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate |
title_full | New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate |
title_fullStr | New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate |
title_full_unstemmed | New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate |
title_short | New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate |
title_sort | new and old horizons for an ancient drug: pharmacokinetics, pharmacodynamics, and clinical perspectives of dimethyl fumarate |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788528/ https://www.ncbi.nlm.nih.gov/pubmed/36559226 http://dx.doi.org/10.3390/pharmaceutics14122732 |
work_keys_str_mv | AT matteopaolinelli newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate AT federicodiotallevi newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate AT emanuelamartina newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate AT giuliaradi newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate AT tommasobianchelli newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate AT alfredogiacchetti newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate AT annacampanati newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate AT annamariaoffidani newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate |